Skip to main content

Table 1 Primary antibodies and dilutions used for the immunohistochemical analyses and results

From: First description of an acinic cell carcinoma of the breast in a BRCA1 mutation carrier: a case report

Antibody to

Manufacturer

Dilution

Results

ER

Ventana

ready-to-use

Negative

PgR

Ventana

ready-to-use

Negative

HER2

Dako

1:1000

Negative

S100 protein

Dako

1:2000

Positive

EMA

Ventana

ready-to-use

Positive

GCDFP15

Signet

1:20

Negative

P53

Novocastra

1:200

Positive

AACT

Dako

1:1000

Positive

Actin

Dako

1:400

Negative

Maspin

Pharmingen

1:500

Negative

Calponin

BioGenex

1:400

Negative

  1. ER, estrogen receptor; PgR, progesterone receptor; HER2, human epidermal growth factor receptor 2; EMA, epithelial membrane antigen; GCDFP15, gross cystic disease fluid protein-15; AACT, alpha-1-antichymotrypsin.